Bayer Aktiengesellschaft Stock Current Valuation
| BAYZF Stock | USD 28.21 0.28 1.00% |
Valuation analysis of Bayer Aktiengesellschaft helps investors to measure Bayer Aktiengesellscha's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Bayer Aktiengesellscha's price fluctuation is very steady at this time. Calculation of the real value of Bayer Aktiengesellschaft is based on 3 months time horizon. Increasing Bayer Aktiengesellscha's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Bayer Aktiengesellschaft is useful when determining the fair value of the Bayer pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Bayer Aktiengesellscha. Since Bayer Aktiengesellscha is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bayer Pink Sheet. However, Bayer Aktiengesellscha's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 28.21 | Real 29.74 | Hype 27.93 |
The real value of Bayer Pink Sheet, also known as its intrinsic value, is the underlying worth of Bayer Aktiengesellschaft Company, which is reflected in its stock price. It is based on Bayer Aktiengesellscha's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Bayer Aktiengesellscha's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bayer Aktiengesellscha's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bayer Aktiengesellschaft helps investors to forecast how Bayer pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bayer Aktiengesellscha more accurately as focusing exclusively on Bayer Aktiengesellscha's fundamentals will not take into account other important factors: Bayer Aktiengesellschaft Company Current Valuation Analysis
Bayer Aktiengesellscha's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bayer Aktiengesellscha Current Valuation | 87.41 B |
Most of Bayer Aktiengesellscha's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bayer Aktiengesellschaft is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Bayer Aktiengesellschaft has a Current Valuation of 87.41 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The current valuation for all United States stocks is significantly lower than that of the firm.
Bayer Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bayer Aktiengesellscha's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bayer Aktiengesellscha could also be used in its relative valuation, which is a method of valuing Bayer Aktiengesellscha by comparing valuation metrics of similar companies.Bayer Aktiengesellscha is currently under evaluation in current valuation category among related companies.
Bayer Fundamentals
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 87.41 B | |||
| Shares Outstanding | 982.42 M | |||
| Shares Owned By Institutions | 47.11 % | |||
| Price To Earning | 321.83 X | |||
| Price To Book | 1.36 X | |||
| Price To Sales | 1.06 X | |||
| Revenue | 44.08 B | |||
| Gross Profit | 27.04 B | |||
| EBITDA | 6.45 B | |||
| Net Income | 1000 M | |||
| Cash And Equivalents | 8.19 B | |||
| Cash Per Share | 8.34 X | |||
| Total Debt | 35.55 B | |||
| Debt To Equity | 1.17 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 42.01 X | |||
| Cash Flow From Operations | 5.09 B | |||
| Earnings Per Share | 5.13 X | |||
| Price To Earnings To Growth | 1.31 X | |||
| Number Of Employees | 102.3 K | |||
| Beta | 1.17 | |||
| Market Capitalization | 64.24 B | |||
| Total Asset | 120.24 B | |||
| Working Capital | 8.49 B | |||
| Current Asset | 25.17 B | |||
| Current Liabilities | 16.68 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 4.07 % | |||
| Net Asset | 120.24 B | |||
| Last Dividend Paid | 2.0 |
About Bayer Aktiengesellscha Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bayer Aktiengesellschaft's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bayer Aktiengesellscha using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bayer Aktiengesellschaft based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bayer Aktiengesellscha in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bayer Aktiengesellscha's short interest history, or implied volatility extrapolated from Bayer Aktiengesellscha options trading.
Pair Trading with Bayer Aktiengesellscha
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bayer Aktiengesellscha position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bayer Aktiengesellscha will appreciate offsetting losses from the drop in the long position's value.Moving together with Bayer Pink Sheet
| 0.68 | RHHBF | Roche Holding AG | PairCorr |
| 0.65 | RHHBY | Roche Holding Earnings Call This Week | PairCorr |
Moving against Bayer Pink Sheet
| 0.83 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
| 0.81 | LLY | Eli Lilly Financial Report 25th of April 2024 | PairCorr |
| 0.8 | AMZN | Amazon Inc Earnings Call This Week | PairCorr |
| 0.72 | TRGP | Targa Resources Financial Report 2nd of May 2024 | PairCorr |
| 0.71 | GE | GE Aerospace Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Bayer Aktiengesellscha could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bayer Aktiengesellscha when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bayer Aktiengesellscha - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bayer Aktiengesellschaft to buy it.
The correlation of Bayer Aktiengesellscha is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bayer Aktiengesellscha moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bayer Aktiengesellschaft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bayer Aktiengesellscha can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bayer Aktiengesellschaft. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Bayer Aktiengesellschaft information on this page should be used as a complementary analysis to other Bayer Aktiengesellscha's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Bayer Pink Sheet analysis
When running Bayer Aktiengesellscha's price analysis, check to measure Bayer Aktiengesellscha's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer Aktiengesellscha is operating at the current time. Most of Bayer Aktiengesellscha's value examination focuses on studying past and present price action to predict the probability of Bayer Aktiengesellscha's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer Aktiengesellscha's price. Additionally, you may evaluate how the addition of Bayer Aktiengesellscha to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |